The Latest Headlines at American Banking and Market News
UBS Group Cuts Norfolk Southern (NYSE:NSC) Price Target to $294.00
Norfolk Southern (NYSE:NSC – Get Free Report) had its price objective reduced by equities research analysts at UBS Group from $302.00 to $294.00 in a research note issued to investors on Thursday, Benzinga reports. The firm... More of this article »
Benchmark Reaffirms “Buy” Rating for Oceaneering International (NYSE:OII)
Oceaneering International (NYSE:OII – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Benchmark in a research note issued on Thursday, Benzinga reports. They currently have a... More of this article »
UBS Group Boosts Owens Corning (NYSE:OC) Price Target to $192.00
Owens Corning (NYSE:OC – Get Free Report) had its price objective raised by analysts at UBS Group from $169.00 to $192.00 in a note issued to investors on Thursday, Benzinga reports. The brokerage presently has a “buy”... More of this article »
Acrivon Therapeutics (NASDAQ:ACRV) Price Target Increased to $30.00 by Analysts at Piper Sandler
Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) had its price objective hoisted by research analysts at Piper Sandler from $26.00 to $30.00 in a note issued to investors on Thursday, Benzinga reports. The firm presently... More of this article »
UBS Group Boosts NVR (NYSE:NVR) Price Target to $8,175.00
NVR (NYSE:NVR – Free Report) had its target price upped by UBS Group from $7,600.00 to $8,175.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have a neutral rating on the construction... More of this article »
Owens Corning (NYSE:OC) Given New $182.00 Price Target at Argus
Owens Corning (NYSE:OC – Get Free Report) had its price target boosted by equities researchers at Argus from $175.00 to $182.00 in a report issued on Thursday, Benzinga reports. The firm presently has a “buy” rating... More of this article »
Acrivon Therapeutics (NASDAQ:ACRV) Given New $17.00 Price Target at JMP Securities
Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report) had its price objective lifted by equities research analysts at JMP Securities from $14.00 to $17.00 in a research note issued to investors on Thursday, Benzinga reports.... More of this article »
Otis Worldwide (NYSE:OTIS) PT Lowered to $98.00
Otis Worldwide (NYSE:OTIS – Get Free Report) had its target price lowered by investment analysts at Wells Fargo & Company from $102.00 to $98.00 in a research note issued on Thursday, Benzinga reports. The firm presently... More of this article »
Bank of N.T. Butterfield & Son’s (NTB) Outperform Rating Reaffirmed at Raymond James
Bank of N.T. Butterfield & Son (NYSE:NTB – Get Free Report)‘s stock had its “outperform” rating reissued by analysts at Raymond James in a note issued to investors on Thursday, Benzinga reports. They presently... More of this article »
Owens Corning (NYSE:OC) Price Target Raised to $172.00
Owens Corning (NYSE:OC – Get Free Report) had its target price increased by equities research analysts at Evercore ISI from $154.00 to $172.00 in a report released on Thursday, Benzinga reports. The firm currently has an “in-line”... More of this article »
Owens Corning (NYSE:OC) PT Raised to $192.00
Owens Corning (NYSE:OC – Get Free Report) had its price target hoisted by analysts at Royal Bank of Canada from $175.00 to $192.00 in a research note issued on Thursday, Benzinga reports. The firm presently has an “outperform”... More of this article »
Bank of N.T. Butterfield & Son (NYSE:NTB) Rating Reiterated by Piper Sandler
Bank of N.T. Butterfield & Son (NYSE:NTB – Get Free Report)‘s stock had its “overweight” rating reissued by analysts at Piper Sandler in a research note issued to investors on Thursday, Benzinga reports.... More of this article »
Otis Worldwide (NYSE:OTIS) Price Target Raised to $105.00
Otis Worldwide (NYSE:OTIS – Get Free Report) had its target price raised by equities researchers at JPMorgan Chase & Co. from $104.00 to $105.00 in a research note issued to investors on Thursday, Benzinga reports. The... More of this article »